Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study-Reference-Cited by-同舟云学术

Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study

Published:2019-01 Issue:1 Volume:80 Page:60-69.e2
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Zouboulis Christos C.,Okun Martin M.,Prens Errol P.,Gniadecki Robert,Foley Peter A.,Lynde Charles,Weisman Jamie,Gu Yihua,Williams David A.,Jemec Gregor B.E.

Publisher

Elsevier BV

Subject

Dermatology

Reference22 articles.

1. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa;Zouboulis;J Eur Acad Dermatol Venereol,2015

2. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa;Gulliver;Rev Endocr Metab Disord,2016

3. The ABC of hidradenitis suppurativa: a validated glossary on how to name lesions;Lipsker;Dermatology,2016

4. Hidradenitis suppurativa/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation;Zouboulis;Dermatol,2015

5. Development and validation of IHS4, a novel dynamic scoring system to assess hidradenitis suppurativa/acne inversa severity;Zouboulis;Br J Dermatol,2017

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Report of successful treatment of follicular occlusion triad with adalimumab and research progress on biologic therapy for follicular occlusion triad;Journal of Dermatological Treatment;2024-09-09

2. Assessing the Role of Adalimumab in Treating Hidradenitis Suppurativa: Findings from a Retrospective Study at a Reference Center;Clinics and Practice;2024-08-27

3. Hidradenitis Suppurativa: New Targets and Emerging Treatments;American Journal of Clinical Dermatology;2024-07-26

4. Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert Panel;Dermatology;2024-07-18

5. Hepatocyte Growth Factor Has Unique Functions in Keratinocytes that Differ from those of IL-17A and TNF and May Contribute to Inflammatory Pathways in Hidradenitis Suppurativa;Journal of Investigative Dermatology;2024-07